Erasca Foundation plans sale of 8,333 shares

Erasca Foundation filed notice under Rule 144 to sell 8,333 shares of Erasca, Inc. common stock through Merrill Lynch on or about 02/17/2026 on NASDAQ, with an aggregate market value of $99,245.03.

Rhea-AI Filing Summary

Erasca Foundation filed notice under Rule 144 to sell 8,333 shares of Erasca, Inc. common stock through Merrill Lynch on or about 02/17/2026 on NASDAQ, with an aggregate market value of $99,245.03.

The foundation acquired 10,193,557 common shares as a donation from Erasca, Inc. on 07/20/2021. Over the past three months it has already sold 8,333 shares on each of 11/17/2025, 12/15/2025, and 01/15/2026, receiving gross proceeds of $21,626.50, $30,438.69, and $68,573.87 respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for Erasca (ERAS) disclose?

The filing shows Erasca Foundation plans to sell 8,333 Erasca common shares. The shares are to be sold via Merrill Lynch on or about 02/17/2026 on NASDAQ, with an aggregate market value of $99,245.03 based on the information provided.

Who is selling Erasca (ERAS) shares under this Form 144?

The seller is Erasca Foundation. The foundation is the person on whose account the securities are to be sold and previously acquired 10,193,557 Erasca common shares by donation from Erasca, Inc. on 07/20/2021, according to the disclosure.

How many Erasca (ERAS) shares has Erasca Foundation recently sold?

The foundation sold 8,333 shares in each of three recent transactions. These sales occurred on 11/17/2025, 12/15/2025, and 01/15/2026, generating gross proceeds of $21,626.50, $30,438.69, and $68,573.87 respectively over the three-month period.

When and how did Erasca Foundation acquire its Erasca (ERAS) shares?

The foundation acquired 10,193,557 Erasca common shares on 07/20/2021. The shares were received as a donation from Erasca, Inc., and the nature of both the acquisition transaction and the payment is described as a donation in the disclosure table.

What is the market context for the planned Erasca (ERAS) share sale?

The planned sale covers 8,333 shares out of 283,711,805 shares outstanding. The aggregate market value for this block is $99,245.03, and the shares are expected to be sold on NASDAQ through Merrill Lynch around 02/17/2026.

Which broker is handling the Erasca (ERAS) Form 144 sale?

Merrill Lynch is the broker named for this planned sale. The filing lists Merrill Lynch’s Rancho Santa Fe, California address as the broker’s address for the 8,333 Erasca common shares to be sold on NASDAQ around 02/17/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 02:27 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001973524
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Erasca, Inc.
SEC File Number	001-40602
Address of Issuer	3115 MERRYFIELD ROW STE 300 San Diego CALIFORNIA 92121
Phone	858-465-6511
Name of Person for Whose Account the Securities are To Be Sold	Erasca Foundation
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Foundation

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 6002 El Tordo PO Box 7297 Rancho Santa Fe CA 92067	8333	99245.03	283711805	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2021	Donation	Erasca, Inc.			10193557	07/20/2021	Donation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	01/15/2026	8333	68573.87
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	12/15/2025	8333	30438.69
Erasca Foundation 3115 MERRYFIELD ROW STE 300 San Diego CA 92121	Common	11/17/2025	8333	21626.5

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/10/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Chacko
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)